Tuesday, 4 April, 2023 - 11:59
US investor backs WA manufacturing
Five months after striking a deal to buy Pfizer’s WA manufacturing operation, Bridgewest Group has completed the purchase and outlined plans to add to its 400 local staff.
NovaCina is the Perth-based manufacturing arm of holding company Bridgewest Perth Pharma, part of the private US investment company Bridgewest Group. It was established in 2023 after Bridgewest Group purchased the sterile injectable manufacturing facility of Pfizer (Perth), a subsidiary of Pfizer Inc.
NovaCina, a contract development and manufacturing organisation, is involved in early-stage drug development to full-scale manufacturing and advanced analytical studies. It supplies drug products to over 90 countries globally, with approvals secured by regulatory bodies including the United States Food and Drug Administration, the Therapeutic Goods Administration, and the EU.
![]() |
NEWS: Tagged in WA Biotech Boom: Reliis and NovaCina's Perfect Partnership | 29 Jul 2024 |
![]() |
NEWS: Tagged in Ex-Pfizer site gets $2m govt cash injection | 14 Nov 2023 |
![]() |
NEWS: Tagged in Foreign buyers seize local opportunities | 02 May 2023 |
![]() |
NEWS: Tagged in US investor backs WA manufacturing | 04 Apr 2023 |
![]() |
ADDED: Added to Manufacturing list | 04 Apr 2023 |
![]() |
NEW ROLE: Brett Alderson, President, Chief Operating Officer | 04 Apr 2023 |